April 22nd 2025
ctDNA levels may help to predict early recurrence for patients with stage III melanoma before adjuvant therapy and during follow-up.
Immune, Targeted Therapies Plus Radiation Ups Survival in Melanoma Patients With Brain Metastases
September 30th 2016Researchers at Moffitt Cancer Center in Tampa, Fla., demonstrated how novel immune and targeted therapies with radiation therapy may improve the outcomes of patients with melanoma who have brain metastases.
Encorafenib and Binimetinib Combo May Help Improve Survival in Patients With BRAF-Mutant Melanoma
September 28th 2016Combining the BRAF inhibitor encorafenib with the MEK inhibitor binimetinib may significantly improve progression-free survival in BRAF mutant melanoma, according to a new phase III trial.